Markets:

Overview

News

Currencies

International

Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

9.170 -0.580 (-5.95%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

65 66 Next >

River Private Wealth announces new round of investment in Novavax, Inc

January 19, 2023

Via AB Newswire

3 Biotech Stocks Under $15 Worth a Second Look in 2023 ↗

January 18, 2023

All three stocks have promising therapies that could drive revenue in the coming years.

Via The Motley Fool

Pfizer (PFE) Stock Falls on Analyst Downgrade ↗

January 17, 2023

Although Pfizer led the charge in forwarding Covid-19 solutions, possibly waning relevancy poses serious concerns for PFE stock.

Via InvestorPlace

2 Down-on-Their-Luck Stocks That Could Go Parabolic ↗

January 17, 2023

Any bit of good news could send these stocks soaring.

Via The Motley Fool

If You Invested $1,000 in Novavax In 2020, This Is How Much You Would Have Today ↗

January 13, 2023

The stock has gone on a wild ride over the past few years.

Via The Motley Fool

Don't Blame the Bear Market for This Growth Stock's Jaw-Dropping Sell-Off ↗

January 12, 2023

Novavax stock would likely have fallen in 2022 even in a bull market.

Via The Motley Fool

With This Big Transition Ahead, Is Novavax a Buy? ↗

January 12, 2023

Novavax stock sank 92% last year.

Via The Motley Fool

What's Going On With Novavax Stock Today? ↗

January 09, 2023

Novavax Inc (NASDAQ: NVAX) shares are trading higher Monday after the company announced a CEO transition.

Via Benzinga

HC Wainwright & Co. Maintains Buy Rating for Novavax: Here's What You Need To Know ↗

January 02, 2023

Via Benzinga

2 Biotechs Making Waves With A Single Product in their Pipeline

January 11, 2023

Catalyst Pharmaceuticals and Harmony Bioscience each have a single product in their respective pipelines, and both show incredible promise.

Via MarketBeat

Nasdaq Bear Market: 3 Remarkable Growth Stocks That Can Double Your Money in 18 Months ↗

January 11, 2023

These innovative growth stocks have the tailwinds necessary to deliver triple-digit returns for their shareholders by mid-2024.

Via The Motley Fool

NVAX Stock Alert: What to Know as Novavax Names New CEO ↗

January 09, 2023

Although a change at the top boosted sentiment for Novavax, the harsh reality is that NVAX stock faces a mountain of worries.

Via InvestorPlace

Why Is Ocugen (OCGN) Stock Up Today? ↗

January 09, 2023

Ocugen is hoping its Indian-made inactivated Covid-19 shot can provide a low-cost boost for those previously given MRNA-based vaccines.

Via InvestorPlace

Is Novavax Stock a Bargain After Falling More Than 90% From Its High? ↗

January 05, 2023

Could the biotech be the ultimate contrarian buy of 2023?

Via The Motley Fool

Better Recovery Story Buy: Teladoc vs. Novavax ↗

December 28, 2022

These stocks each sank more than 70% this year.

Via The Motley Fool

Is There Any Hope for Novavax? ↗

December 22, 2022

The near term looks complicated for this biotech player.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

January 04, 2023

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

How 'Covid Darling' Pfizer Became A 'Show Me' Story For 2023 ↗

January 04, 2023

Sales of Paxlovid and Comirnaty are expected to continue declining this year and next.

Via Investor's Business Daily

Analyzing Novavax's Short Interest ↗

January 03, 2023

Novavax's (NASDAQ:NVAX) short percent of float has fallen 4.15% since its last report. The company recently reported that it has 24.47 million shares sold short, which is 28.87% of all regular shares...

Via Benzinga

US Stocks On Track To Start 2023 On Upbeat Note: Investors Shrug Off Past Year's Dismal Show And Pin Hopes On A Rebound ↗

January 03, 2023

Trading in the U.S. index futures suggests that stocks may get off to a strong start in the first trading session of 2023. The mood is in contrast to the cautious outlook given by most Wall Street...

Via Benzinga

7 Sensational Stocks That Can Double Your Money in 2023 ↗

January 03, 2023

Triple-digit returns could be just a click away from the buy button.

Via The Motley Fool

What You Missed On Wall Street On Friday ↗

December 31, 2022

In the midst of markets falling, some companies had good news, while others took a hit from analysts and a merger is still on hold.

Via Talk Markets

2 Growth Stocks to Buy Heading Into 2023 ↗

December 30, 2022

These biotechs are far from having achieved their full potential.

Via The Motley Fool

Novavax Kickstarts Phase 2 Trial For COVID-19-Flu Combo, Stand-Alone Flu Vaccine Candidates ↗

December 30, 2022

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

December 27, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Got $1,000? 5 Sensational Stocks to Buy to Start 2023 With a Bang ↗

December 26, 2022

You don't need a mountain of money to grow your wealth on Wall Street.

Via The Motley Fool

Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session ↗

December 29, 2022

Gainers Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001.

Via Benzinga

Three Pharma Stocks to Sell Before They Die ↗

December 24, 2022

As we head into New Year 2023, these are just some of the top pharma stocks to sell at the start of January.

Via InvestorPlace

The Best And Worst Performing Stocks Of 2022 (Through 12/22) ↗

December 23, 2022

A look at the best and worst performing Russell 1,000 stocks year-to-date on a total return basis.

Via Talk Markets

Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session ↗

December 16, 2022

Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share.

Via Benzinga

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

65 66 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Novavax, Inc. - Common Stock (NQ:NVAX)

All News about Novavax, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today